logo dark logoo light logo
  • HOME
  • INVESTMENT & PARTNERSHIP
  • PORTFOLIO
  • ABOUT US
  • NEWS
  • CONTACT
logo dark logoo light logo
  • HOME
  • INVESTMENT & PARTNERSHIP
  • PORTFOLIO
  • ABOUT US
  • NEWS
  • CONTACT
mobile logo
  • HOME
  • INVESTMENT & PARTNERSHIP
  • PORTFOLIO
  • ABOUT US
  • NEWS
  • CONTACT
 

BIONURE APPOINTS DR. LUCIA SEPTIEN AS CHIEF MEDICAL OFFICER

BIONURE APPOINTS DR. LUCIA SEPTIEN AS CHIEF MEDICAL OFFICER

May 15, 2019

Dr Septien brings extensive experience in CNS conditions to neuroprotection biotech

Recent Posts

  • CONNECTA THERAPEUTICS ANNOUNCES FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF FRAGILE X SYNDROME PROGRAM

  • PROUS INSTITUTE PRESENTS THE 12TH EDITION OF THE PROUS INSTITUTE - OVERTON & MEYER AWARD FOR NEW TECHNOLOGIES IN DRUG DISCOVERY TO PROF. TIMOTHY NOËL (UNIVERSITY OF AMSTERDAM, THE NETHERLANDS)

  • CONNECTA THERAPEUTICS, A SPIN-OFF OF THE PROUS INSTITUTE FOR BIOMEDICAL RESEARCH, INITIATES PHASE IIA CLINICAL TRIAL OF CTH120, A FIRST-IN-CLASS NEUROPLASTICITY MODULATOR, IN FRAGILE X SYNDROME

  • PROUS INSTITUTE INVESTS IN D-SIGHT, A CLINICAL-STAGE SPIN-OFF FROM THE VALL D’HEBRON RESEARCH INSTITUTE (VHIR) FOCUSED ON THE DEVELOPMENT OF NEUROPROTECTIVE THERAPIES FOR OCULAR DISEASES

  • The VHIR and Prous Institute will promote high-impact research projects in early stages of development

  • CONNECTA THERAPEUTICS, A SPIN-OFF OF THE PROUS INSTITUTE FOR BIOMEDICAL RESEARCH, ANNOUNCES POSITIVE RESULTS FROM PHASE I STUDY OF NEURODEVELOPMENTAL DISORDERS DRUG CANDIDATE, CTH120

About Us

Prous Institute, created as a spin-off of Prous Science (acquired by Thomson Reuters, now Clarivate Analytics, in 2007) is committed to supporting the discovery of novel therapeutic and diagnostic approaches.

Prous Institute, originally founded by Dr. J.R. Prous, has evolved to expand its mission beyond its own developments by partnering and investing in transformative science initiatives.

By leveraging more than 60 years’ experience in the life sciences, we offer the resources and capabilities needed by researchers to move their research closer to the patient bedside.

  • Contact
  • Copyright and Legal Notice
  • Privacy Policy
  • Cookie Policy
© 2026 All Right Reserved